A comprehensive view of biontech se. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to GENMAB, BioNTech on March 26 for "Multispecific antibodies against CD40 and CD137" (Dutch, German Inventors)

BioNTech receives a notice of default from the NIH over allegedly owed vaccine royalties under a prior licensing agreement

INTERNATIONAL PATENT: BIONTECH SE, TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH FILES APPLICATION FOR "SYSTEMS AND COMPOSITIONS COMPRISING TRANS-AMPLIFYING RNA VECTORS WITH MIRNA"

BioNTech reports Q4 net profit of US$497.0M, Q4 revenue of US$1.6B; full-year net income drops 90% year-over-year to US$1.0B, revenue down 90% YoY to US$4.14B

BioNTech announces fourth quarter and full year 2023 financial results and corporate update

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count